Clinical Trial

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-10
Trial Details
NCT Number NCT07509775
Lead Sponsor China-Japan Friendship Hospital
Collaborators: The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Guangxi Ruikang Hospital, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Beijing Electric Power Hospital, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Xi'an Fifth Hospital, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Longhua Hospital, Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital
Conditions Ankylosing Spondylitis (AS)
Enrollment 210 participants
Start Date 2026-01-19
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-09